Form D — Mivax Therapeutics, Inc.
0002066303-26-000001 · filed 2026-01-23
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $500,000
- Total sold
- $107,500
- Minimum investment
- $2,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Mivax Therapeutics, Inc.
- CIK
- 2066303
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 701 CHINA BASIN ST
SAN FRANCISCO, CA 94158 - Phone
- 7857706160
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Viraj Balkrishna Deshpande · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Pragyesh Dhungel · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.